Martin Wolf Selected Research

Martin Wolf Research Topics

Disease

8	Neoplasms (Cancer) 10/2023 - 01/2006
6	Hypoxia (Hypoxemia) 10/2022 - 11/2004
6	Hypersensitivity (Allergy) 11/2020 - 07/2014
4	Hemorrhage 01/2021 - 08/2008
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2019 - 07/2015
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 08/2015 - 08/2004
2	Wounds and Injuries (Trauma) 01/2021 - 08/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 10/2020
2	Stroke (Strokes) 01/2020 - 01/2011
2	Diarrhea 01/2018 - 08/2013
2	Apnea 08/2014 - 02/2010
2	Inflammation (Inflammations) 07/2014 - 01/2014
2	Carcinoma (Carcinomatosis) 03/2014 - 12/2013
2	Brain Injuries (Brain Injury) 11/2011 - 08/2008
2	Birth Weight (Birth Weights) 01/2005 - 04/2002
1	Lung Neoplasms (Lung Cancer) 10/2023
1	Persistent Vegetative State (Vegetative State) 08/2022
1	Alzheimer Disease (Alzheimer's Disease) 07/2022
1	Amyloidosis 07/2022
1	Carcinogenesis 01/2021
1	Disease Progression 01/2021
1	Seasonal Allergic Rhinitis (Hay Fever) 11/2020
1	Adenocarcinoma 10/2020
1	Hematoma 01/2020
1	Cerebral Hemorrhage 01/2020
1	Supraventricular Tachycardia 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Ischemic Stroke 10/2015
1	Sleep Apnea Syndromes (Sleep Apnea) 08/2014
1	Sepsis (Septicemia) 07/2014
1	Renal Cell Carcinoma (Grawitz Tumor) 03/2014
1	Pain (Aches) 03/2014
1	Fetal Distress 01/2014
1	Acute Kidney Injury (Acute Renal Failure) 01/2014

Drug/Important Bio-Agent (IBA)

8	Hemoglobins (Hemoglobin)IBA 08/2014 - 04/2002
5	AllergensIBA 11/2020 - 07/2014
5	Cisplatin (Platino)FDA LinkGeneric 06/2019 - 09/2012
4	Oxygen (Dioxygen)IBA 04/2021 - 04/2002
4	Gemcitabine FDA Link 01/2021 - 07/2015
3	PlatinumIBA 01/2021 - 08/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2019 - 07/2015
2	Bevacizumab (Avastin)FDA Link 06/2019 - 07/2015
2	VaccinesIBA 06/2017 - 07/2014
2	Topotecan (Hycamtin)FDA LinkGeneric 08/2015 - 09/2012
2	5-fluorouridineIBA 03/2014 - 12/2013
2	Fluorouracil (Carac)FDA LinkGeneric 03/2014 - 12/2013
2	Cytostatic AgentsIBA 03/2014 - 12/2013
2	Carbon DioxideIBA 03/2014 - 01/2005
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Amyloid beta-PeptidesIBA 07/2022
1	CurcuminIBA 07/2022
1	Fluorescent Dyes (Fluorescent Probes)IBA 07/2022
1	pimonidazoleIBA 04/2021
1	LigandsIBA 01/2021
1	SuspensionsIBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	paragonIBA 01/2021
1	130-nm albumin-bound paclitaxelIBA 01/2021
1	rovalpituzumab tesirineIBA 01/2021
1	Atu027IBA 10/2020
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2020
1	Hemostatics (Antihemorrhagics)IBA 01/2020
1	Cadherins (E-Cadherin)IBA 06/2019
1	Prostaglandins BIBA 06/2019
1	Biomarkers (Surrogate Marker)IBA 06/2019
1	VimentinIBA 06/2019
1	Codon (Codons)IBA 01/2018
1	Epithelial Cell Adhesion MoleculeIBA 01/2018
1	EnzymesIBA 01/2018
1	IpilimumabIBA 01/2018
1	SolitomabIBA 01/2018
1	Recombinant ProteinsIBA 01/2018
1	Lipase (Acid Lipase)FDA Link 01/2018
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2017
1	Peptides (Polypeptides)IBA 06/2017
1	Proteins (Proteins, Gene)FDA Link 06/2017
1	Pemetrexed (MTA)FDA Link 12/2015
1	Carboplatin (JM8)FDA LinkGeneric 12/2015
1	N(4)-oleylcytosine arabinosideIBA 10/2015
1	RivaroxabanIBA 10/2015
1	Taxoids (Taxanes)IBA 08/2015
1	taxaneIBA 08/2015
1	cabazitaxel FDA Link 08/2015
1	Acetazolamide (Diamox)FDA LinkGeneric 08/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014
1	Caspase 3 (Caspase-3)IBA 03/2014
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2014
1	EicosanoidsIBA 01/2014

Therapy/Procedure

10	Therapeutics 10/2023 - 01/2006
7	Drug Therapy (Chemotherapy) 10/2023 - 08/2004
3	Immunotherapy 11/2020 - 06/2017
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2021 - 01/2020
2	Critical Care (Surgical Intensive Care) 11/2011 - 08/2008
1	Chemoradiotherapy 10/2023
1	Erythrocyte Transfusion 01/2021
1	Transplantation 01/2021
1	Heterologous Transplantation (Xenotransplantation) 01/2021
1	Oral Administration 01/2017
1	Adjuvant Chemotherapy 12/2015